AlerisLife Inc. (ALR)
NASDAQ: ALR · IEX Real-Time Price · USD
1.32
+0.01 (0.76%)
Mar 17, 2023, 4:00 PM EDT - Market closed
Stock Price Forecast
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for AlerisLife stock from 8 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 4 | 4 | 4 | 4 | 4 | 4 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 8 | 8 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
725.93M
from 934.59M
Decreased by
-22.33%
Revenue Next Year
835.94M
from 725.93M
Increased by
15.15%
EPS This Year
-1.05
from -0.95
EPS Next Year
-0.55
from -1.05
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Revenue | 1.40B | 1.39B | 1.42B | 1.16B | 934.59M | 725.93M | 835.94M | 920.53M |
Revenue Growth | 1.31% | -0.41% | 1.78% | -17.77% | -19.69% | -22.33% | 15.15% | 10.12% |
EPS | -4.20 | -14.91 | -3.99 | -0.24 | -0.95 | -1.05 | -0.55 | -0.20 |
EPS Growth | - | - | - | - | - | - | - | - |
No. Analysts | - | - | - | - | - | 2 | 2 | 2 |
Revenue Forecast
Revenue | 2022 | 2023 | 2024 |
---|---|---|---|
High | 754.7M | 869.1M | 957.0M |
Avg | 725.9M | 835.9M | 920.5M |
Low | 704.4M | 811.1M | 893.2M |
Revenue Growth
Revenue Growth | 2022 | 2023 | 2024 |
---|---|---|---|
High | -19.3%
| 19.7%
| 14.5%
|
Avg | -22.3%
| 15.2%
| 10.1%
|
Low | -24.6%
| 11.7%
| 6.8%
|
EPS Forecast
EPS | 2022 | 2023 | 2024 |
---|---|---|---|
High | -1.09 | -0.57 | -0.21 |
Avg | -1.05 | -0.55 | -0.20 |
Low | -1.02 | -0.53 | -0.20 |
EPS Growth
EPS Growth | 2022 | 2023 | 2024 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.